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Although the host response to gram-negative bacterial infection follows largely from the interactions of 
bacterial lipopolysaccharides (LPS or endotoxin) witb host cells, little information is available concerning the 
mechanisms by which the host eliminates or detoxifies LPS, AcyloxyacyJ hydrolase (AOAH) is an enzyme, found 
in phagocytic cells. that catalyzes the enzymatic deacylation of the lipid A moiety of LPS. Enzymatically 
deacylated LPS is much Jess potent than LPS at inducing responses in human cells, and it can antagonize the 
ability of LPS to activate human macrophages, neutrophils, and endothelial cells, Despite these observations, 
the physiologic role of LPS deacylation remains undefined. To invest.igate the ability of AOAH to carry out LPS 
deacylation in vivo, we produced a recombinant adenovirus carrying a gene encoding AOAH (Ad.CMV·AOAH) 
and employed Ihis vector to elicit transient overexpression of AOAH in mice. Mice infected witb Ad.CMV­
AOAH expressed high levels of the enzyme in plasma, liver, spleen, and kidney. Although adenovirus·induced 
hepatitis reduced hepatic uptake of intravenously injected [3H]LPS, animals expressing the transgeue deacy­
lated a larger fraction of the [3H]LPS taken up by their livers tban did mice infected with a control adenovirus. 
These studies indicate that AOAH can catalyze the deacylation of LPS in vivo, and they provide evidence that 
the rates of hepatic LPS uptake and deacylation are not closely linked. 
The capacity of hOSl phagocytic cells to activate in response 
to bacterial lipopolysaccharide (LPS or endotoxin) is an im­
portant defense against gram-negative bacterial infeetion. This 
aetivation is triggered largely hy interactions of the lipid A 
moiety of LPS with critical host eells, mediated by binding LPS 
lo cellular CD14. Allhough much has been learned reeently 
about host systems for recognizing and responding to LPS, 
relatively little is known about the meehanisms by which LPS is 
detoxified in vivo. Sinee an excessive response to LPS may have 
deleterious effects culminating in the syndrome of septic shock, 
there is substantial medical interCSl in these mechanisms and 
in the development of strategies to limit the host response to 
LPS. 
Previous studies from this laboratory have explored the po­
tential endotoxin-detoxifying role of acyloxyacyl hydrolase 
(AOAR) , a phagocytic cell enzyme that removes secondary 
acyl chains from the lipid A moiety of LPS (11). Enzymatically 
deacylated LPS (dLPS) is 10o-fold less potent than LPS at 
eliciting the dermal Shwartzman reaction in rabbits (22). In 
vitro, dLPS is also substantially less active than LPS at stimu­
lating human monocytes, neulrophils, and endothelial cells 
(25). Moreover, it eompetitively inhibits binding of LPS to 
CD14 at concentrations near its binding Kd (14) and potentJy 
antagonizes the ability of LPS to stimulate NF-KB binding 
activity and interleukin 1 and interleukin 8 release from human 
cells (14, 15). Enzymatic deacylation of LPS by AOAR might 
thus function both to detoxify LPS and to generate an LPS 
antagonist in humans. 
While the activily of AOAH and the effects of dLPS have 
been characterized in cultured cells, the function(s) of AOAH 
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in vivo has not been examined previously. One approach to 
cvaluating the biological role of a moleeule is to examine thc 
eonsequences of increasing its abundance. This may be aecom­
plished by directly administering thc molecule to animals, by 
creating transgenic animals that overexpress it, or by tran­
sicntly overexpressing a gene that encodes it following in vivo 
gene transfer. To investigate the role of AOAH, we con­
structed a rccombinant adenovirus carrying a gene in which a 
cDNA coding for human AOAH is expressed from the human 
cytomegalovirus immediate-early promoter-enhancer (Ad.­
CMV-AOAH). On the basis of our prior observations of for­
eign gene expression following systemic administration of re­
combinant adenoviruses (12,17,26), we antieipated that intra­
venous administration of lhis recombinant adenovirus to mice 
would result in transient, constitutive overexpression of the 
human enzyme in the liver. Since the liver is the principal site 
of uptake of LPS from the circulation, we reasoned that he­
patic overexpression of AOAH migh! accelerate LPS deacyla­
tion. In addition, if hepatically synthesized AOAR were re­
leased into the circulation, interaction of AOAH with 
circulating LPS might alter LPS clearance from the plasma 
space. Since both dLPS (22) and other tetraacyllipid A analogs 
(8,18) retain much of the potency of LPS in mice, on the other 
hand, AOAH overproduction would not be expected to protect 
mice against LPS challenge. 
We now describe experiments demonstrating that intrave­
nous administration of Ad.CMV-AOAH to mice results in 
striking increases in AOAH activity in the liver, spleen, and 
kidney and that overexpression of AOAH in the liver produces 
a proportional increase in the rate at which intravenously ad­
ministered ['H]LPS undergoes hepatic deacylation. Overex­
pression of AOAH also increased enzyme activity in plasma. 
yet the deacylation of f'HJLPS in the plasma space was not 
enhanced and the rates of clearance of rough- and smooth­
form LPS from the plasma space were not altered. 
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MATERIALS AND METHODS 
Reagents. Chemicals were purchased from Sigma Chemical Co. (SI. Louis, 
Mo.) unless otherwise slated. All solutions were prepared in baked glassware 
wllh pyrogen-lree waler (Baxter Heallhcarc, Deerfield. 111.). and tissue cui lure 
med)~ u;seu Ln virus pre::paraliun wert:. pl"e~(:Ire<.J b'y us: of luw-endoloxlO rc~aJ 
hOVlnc serum (HyClone, Logan, Utah). I H, I4CJLP~, useu as subslral. lor 
enZyme assays, was prepared from Snlmondla typhmmrillm as described previ­
ously (21). Rough I'II)LPS wa. prepared Jrom f:;;c!lcndllo col, LCD25 (2U): lIS 
speellic actiVlCY was 2 x JU' dpm/lJ,g. Smooth (O-antigen-containing) l'II]LPS 
was prepared from S l)'Phllmll'l1llll G-30, grown in the presence 01 (i) I'Hlacetate 
and LO mM D-galaetose (II) or (ii) ,'Hlgalactnse and 0.05 mM nonradloaelive 
D-galaclOse (23). The smo<>lh LPS were isnlated hy 'Iandard phennl-warer ex­
lraCllOn followed by extensjve elher washes 10 remove ront,lmmaling phospho­
lipids (2J). Thelf specific acLivilies were 2,UOO aud 75,000 dpm/lJ,g, respectively. 
Preparation of recombinanf adenoviruses. The recombinant adenOVirus Ad. 
CMV-AOAH was generated by homologous recombmallon beTWeen sub­
S!t:-numk fragmcnl$ of a mudHleJ i:ldcnovilus g~nom.: In 293 cell.') 'dS desuiht::d 
previously 0). Briefly, a full-length eDNA enroding hnman AOAH (W) was 
subdoned into the plasmid pACCMV.pLpA (7), and the resuillng plasm,u (l0 
IJ,~) wa" (olranslecteu IOto 29.' cell; with 5 )Lg 01 Xbrrl-dtgcslcu ADuB09 DNA 
hy calcium phosphate copre(tpilalion wil h a glycerol shock to hoosl lranslection 
efficicn~:y. Homolngous recomhinannn nelween the pAC rla~mid and the right 
91 % fragment of the viral genome resulted in the [ormal;on of a recombiuant 
viral genome of packageable SIZe in which the CMV-AOAH fnsion gene replaces 
lhe nallve adenovirus early reeion 1. 
Clonally derived recombinant virnses were isola led and propagated as de­
sCtlhe.u pre'lOusly (17) dnu ch.rarlerized hy reSltlchun an.lyst> .nd Sonth<rn 
blOlling of viral DNA prcpared from productively 1IlIc(l<d 293 cells. Recombi­
nant viruses were SHbcJoned IWlce to ensure punty. Generalion 01 the (ecomol­
nant adenovlCuses Ad CMV-Lne, earrying a gene encodIng firefly lncilCrase, and 
AJ.CMV-t,3gal, carrymg a gene encoding a nntlear.)o<:allzing varjant oj F; colt 
l3-galaelo'idase, I,ave been descnhed elsewhere (12). 
La,rgt'...scale virus preparation. Large-seale adenovuu~ proJuchon was per­
formed folloWIng inJection oJ 293 ceJls grown 10 confluence in Duloecco modl­
lied Eagle medium conlaining 10% lelal bovine .serum InfeCled celis were lysed 
with O. I% Nonidel 1'-40. and the cellular debris was removed byeeulrifugation 
al 12,000 x 8 for 10 mm al 4'C. Virus panicles were preClpilaled by add 109 0.5 
volume ot' a sululton containing 2U% (v.1lvol) pulyelhylene glycul ~UOU and 2.5 M 
NaCi and then mcub.led On ice fnr 1 h. TI,e Vtrus was collecled by centrifugallOn 
112,000 x g, 20 mm, 4'C), resuspended 10 J.1 g ofCsCI per ml in 20 mM TItS-IlO 
(pH 7.4), and lurlher puriHed by ultr~cenlrifugation over a CsCI step gradient. 
Bandeu virus was collected and desalt.ed hy chromatography over a Sepharose 
CL-4B enl~mn In an (sotnnie ""line hulfe, (135 mM NaC!, 5 mM Ket, , 10M 
MgC12• 20 10M Tris-llCI [pll 7.4]) as dnscrihed previously (7). The virus was 
collected aller elUl.ion from the column, and Jow-endotuxin bovwe sernm albu­
min (BSA) was auded (final concentralion, (00 ~.glml) pnor In storage al -70'C. 
Viral titer was delermlned hy plaque assay on confluenl monnlayers nt' 293 cell.' 
(9). 
Animal procedures. Male ICR and BALBle mice (20 lO 24 g) were purchased 
Irom Harlan (Indianapolis. Ind.) and housed and fed ad lib.tum in the Animal 
Resources CenLer. All ammal procedures and experirnenLs were conducted In 
rlL'Cnrdancc with Nallunal Jn$tjlule~ of Ht::iJllh gUI(J~hnt:~ anti Wider pro(w.:o}s 
approved by (he Inslitulional Antmal C"e and Research Advisory Committee 01 
lhe Unlversily of Texas Southwestern Medll'al Center at Dallas. All procedures 
were pert'ormed while Ihe mice were under anestheSta oblained by intraperito­
neal Injecllon of sodium pentobarbilal (l00 )Lg/g oJ body weighl). Adenoviruses 
were inlecled JIIto Ihe tail vein In a vnlume ,,1251l)L1. Blood sample, were lakeu 
by punl'ture oILhe retroorbital vein. Mice were ellihanized by cervical dIslocation 
following sedation by intraperitoneal injection of sodium penlobarbtlal (100 IJ,glg 
of hodv weight). Organs or tissue slices were weighed and homogenized (Tissue 
Tearo~, Biospee Producls, BarLleSVllle, Okla.) in lySIS buffer (phosphale-buU'ered 
sahn~, 0.2% Tntou X·IOO, 2.5 mM EDTA, U.2 InM phcnY)m~thylsulfunyl Ouu­
ride, 0.5 )Lg of leupeplln per ml, 0.5 IJ,g 01 aprollnin per ml,l mg 01 BSA per 011) 
al 4'C and stored at - 20'C 
Assays. A0A11 aClivily was mea.,~red a, described prevlolL,ly (21), Samples 
were incubated overnight a1 37'C with 0.5 )Lg of I'H, 14CJLl'S In a reactIOn 
mixlure lhal contained 0 1% Triton X- tOO, 20 mM Tris-eilCate (pll 4.8),150 mM 
NaCl, and 1 mg 01 BSA per ml in a volume oj 0.5 ml (21). Followlng e.hanol 
pree.pllation 01 the LPS, the 'H-fally acius remaimng JI1 the supernalant were 
counted in a Mtnaxi Tricorb 411111l bela ,et.nullalJon counter (Packard Instru­
ments, Laguna Hills, Caltr.). The speeitie activlly of Ihe acyl ehalOs m the LPS 
suhmale waS approxlfnale!y 50.0UO 'H dpmlnmoJ. Lueiferase activity in liver 
tissue was determined as described previously (J, 27). 
Determinat.ion of LPS deacylation, dearanct) aDd distribnljon, Plasma clcar­
anee of rough ['HlLPS was determined hy inlravenous lUJe':lion or 10 )Lg of E 
m}, LC025 ['HlLI'S (ur a mix~ure lhat conlalned 1 )Lg ul rough ('HILI'S and 9 
)L~ ul nonradiuaclive L<":025 LP~) 3 or 4 uay~ aller micc had been IO!cctcd with 
1 -X 10' to 2 X 10· PFU 01 Ad.CMV-AOAH, Ad.CMV-~Gal, or saline, Mire 
were eUlhamzed at 5 mlU, 30 nun. or 6 h after LI'S administration. Approxl­
Jnaiely 0.5 ml of blood w....s COllcl'lcd into mlCf()CCnlnt'ngc luhes conLi~.injng 5 JJ.I 
01 () 27 M EDTA, and the 'H in the aliqnols orpl.sma wa>eoumed 10lJowlng Ihe 
200 
it 
>­
~ 150
.::; # # 
~ 
u 
~ 100 
I 
« 
0 50
« 
FIG. 
250 IJ,I 01 saline (open bars) Or an equal volume of saline eontalmng 2.5 X 10' 
PFU of Ad.CMV-~Gal(suppled bars) or Ad.CMV-AOAH (shaded hars). Arter 
4 uay~. samples III the IOd,cateu Li>suc, were harvestcd and 'd55ayed for AOAl1 
aruVlty. Artivity is eJ(pre.sed as 'H dpm (10') released from the labeled LPS 
substrate during 19 h 01 incuhalion al 37"C (per milligram of lissue). Data are 
expressed as mean::!: sI3ndard error o1thc mcan tor Ci::1ch treatmenl. Symbols: *. 
P < 0.05 versus sahne-injected animals, #. P < 0.05 versus saline- and Ad.CMV­
~Gal-inlected anImal,. 
addition of sodium dodecyl sult'ale-EDTA (8) and scintillant. The lheorelieal 
imlial (I,,) plasn,a eoncenlralion oq'H1LPS was delermined by dividIOg Ihe lolal 
dose administered by Ihe plasma volume (In m,lhlJlers), calculated as [animal 
wClght (grams)] X {bloou volnme (0 OR mUg)l X P - hemalOL'rH. or 0.45]. The 
pen.:enta,ge o( the Inllifll 'H rem;lining In Ihe plasma at the various time poinls 
was Ihen calculated. Organl" were weighed and hnmogenJ7.ed as descrihed IlOnve. 
Smonth LPS clearance Irnm pla'ma wa.' determined 4 dap. t'nllowmg mJeCllnn 
of i X 10" lO 2 X 10') rFU of Ad,CMV·AOAH, Ad.CMV-j3Gal. or saHne. Mice 
were bled al5 min, 60 min, or 6 h aHer iutravenous injeelion of eilher 100 ~.g of 
smooth ['Hlaeetate-Iabclecl LI'S (rwo experiments) or 5 )J.g of (-'UlgalaelOse­
labeled LPS (one e><periment), and the plasma LPS eoneelHralions were ex­
prcsscu as a pcrc~ntdgt "I' ~he inillal plasma l 'HjLPS concentration as described 
d~lOVc. 
In the rough and the I'HJaeetate-laheled smooth LPS, essentially all ollhe 'H 
dlSlntcgrations pcr minntc arc In fany acyl chains (20). I'JIjLPS dcacylation iu 
liver nr plasma was delermlned by mcasunng Ihe IOta I anu ethanol-soluble 'II. 
Thlety minutes aILer inlravenous InJcWon of I'HlLI'S, ahqnOls 01 liver homo­
genalc" in lysIS hulfer were mixed wilh ethann] (1 volume nl Iysale 10 ,volume, 
of ethanol), held al -20"C for 2 h, and lhen eenlClfuged (12,000 x g, lU min, 
4°C). The 'H remaining in Ihe snpernalanl (I.e., no longer pan ohhc LPS, which 
is ethanol insoluble) was eounled. The lotal 'H in Ihe salliptes was also counled, 
and the fraellon of 'H 10 the ethanol supernalant.. was expressEd a, a percenlage. 
Uuder oplimal eoudilions. AOAH can remove approxir,nalely 30'1<. of Ihe 'H 
from 1~'HJLI'S (lWO 01 th~ six t'ally acyl chains io the LPS) 
DAt. analysis. Group dala were analyzed by An'dlySIS uf Vartance (Kwiksl.l 
VerslOu 4; TexaSofL. Dallas, Tex.) and the Newman-Keuls multIple comparison 
test. D,ft'erenees al the level of l' of <0.U5 were conSIdered slg",~cant. Relallon­
shjps between liver and plasma enzyme acilviues were examined hy Hnear re­
grc.loislon. 
RESULTS 
Mice injected intravenously with Ad.CMV-AOAH demon­
strated significant increases in AOAH activity in the liver, 
spleen, and kidney 3 to 4 days after infection (Fig. 1). Enzyme 
aclivitv in liver tissue harvested from Ad.CMV-AOAH-in­
fectect' animals was more than 40-fold greater than that in 
lissue harvested from uninfected control animals and more 
than lO-fold greater than that in liver from animals infected 
with the irrelevant virus Ad.CMV-j3Gal. Notably, animals in­
fected with Ad.CMV-j3Gal showed a small hut significanl in­
crease in tissue AOAH activity over that of unirrfected control 
animals (Fig, 1). 
l. AOAH activity in tisslles. M,ce (four per group) were injected wllh 
I 
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FIG. 2. Time COurse of plasma AOAH aClivity in Ad.CMY-AOAH-lnfecled 
and conlrol mice. Mice were InJccled wilh 250 ",I of salme (n ~ 5; open bars) or 
an e'lual vulume uJ' saline wnlailling 2 X 10· PFU ur At.l.CMY-llGal (n = 5; 
slippled bars) ur Al!.CMY·AOAH (II ~ 9; shadel! bars). Blood sampb fur 
delerminalion oj plasma AOAlI aClivity were obtained 3, 6, 10, and l3 days afier 
m.lcclton. Sec Iegcnd 10 FIg. 1 lor dcf'llIlllons of AOAII aellvlty and symbols 
Overexpression of AOAH in infected mice was associated 
with a significanl but transient increase in plasma AOAH ac­
tivity (Fig. 2 and data not shown). Three days after infection, 
plasma enzyme aetivity in Ad.CMV-AOAH-infected animals 
was 5- to 10-fold greater than that in uninfeeted or Ad.CMV­
f3Gal-infeeted eontrols. Plasma AOAH aetivity peaked 4 to 6 
days after infection at levels more than 20-fold greater than 
those in uninfected controls. At 10 and 13 days after infeeljon, 
plasma AOAH activities were not significantly different from 
levels in animals infecled with the conlrol recombinant adeno­
virus. There was a strong correlation between plasma and liver 
AOAH activities in individual animals following infection with 
Ad.CMV-AOAH (n = 13 mice; r = 0.86, P = 0.0001). 
LPS exists in two forms, S or smooth (O-antigen containing) 
and R or rough (lacking 0 antigcn), which are cleared from 
plasma in different ways. While the fornler (like the LPS in 
intravenously injected bacteria [6]) is initially cleared almost 
exclusively by phagocytie cells (KupfIer cells and iutravascular 
granulocytes), the latter is cleared principally by hepatocytes 
(3, 13). Bccause systemic adminislration of recombinant ade­
novirus is associaled with preferential infection of hepatocytes 
(12), we examined the rate of deacylation of rough [3H)LPS to 
del.ermine whelher ovcrexpression of AOAH would increase 
the rate of intracellular LPS deacylalion in vivo. The LPS 
deacylation rate was determined by measuring the fraction of 
the radiolabel that appeared in an ethanol-soluble form in 
hepatic tissue harvested from saline, Ad.CMV-f3Gal-, and Ad. 
CMV-AOAH-injected animals 30 min following intravenous 
administration of rough-form [~H]LPS. As shown in Fig. 3A, 
infection of mice with Ad.CMV-AOAH resulted in a signifi­
cantly increased (approximately sixfold, P < 0.05) rate of he­
patic LPS deacylation in comparison with that of control ani­
mals. Similar results wcre found in another experiment (Table 
1). In view of the fact rhat AOAH removes only two of the six 
acyl chains from the lipid A moiety of LPS, the observed 
release of 4 to 6% of the radiolabel from rough LPS over the 
30-min study period is eonsistcnt with enzymatic deacylaUon of 
approximately 12 to 18% of the liver-associated LPS within this 
timc period. There was a positive correlation between the rate 
of in vivo hepatic deacylation of rough LPS and the assayed 
hepatic AOAH activity (Fig. 3B). 
INFECT. IMMUN. 
Saline 6-gat AOAH 
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r = 0.62 
p = 0.023 
100 200 300 400 
Liver AOAH activity 
FIG. 3. In VIVO deacyla1ion of ['H)ruugh LPS in Ad.CMV-AOAH-infecled 
and eonlCol m>ee. (A) Mice were inJecled intravenously With T:: ((Iii LCD25 
I'HjLPS 3 days after inJccllOn ot 250 ",1 of .allne (n = 5) or an equal volume of 
saline cuntaining2 X JO"PFU ofAd.CMV-pGal (n ~ 7) or Ad.CMV-AOAJ-I (n 
~ 13). Aller 30 mm, livers were harvested and lOlal and elhanol-soluble 'H 
radioactivitIes were dClcrminel!. Dala are e~pressed as the fraellon (percenl) of 
10lal 'H dpm in the elhanol-soluble [racLlon (mean:!: slandard error of Ihe 
mean). Symbols: " P < 0.05 versus saline-inJected and Ad.CMY-pGal-mfeeted 
aninlal~. Rl;"sult.s from'" similar ex~erirnenl an~ shown in Table}. (B) Correlation 
between in vivo deacylalion uf . H-Iabded LCD25 LPS and hepalic AOAH 
.e[jvlly {delermined in hep'uc L1ssue harvesled from the Ad.CMY·AOAfI­
inlcclcd animal' shown in panel A aCler SOO-fold dilulion lO cllmillale assay 
inlerference by r'HjLPS in the L1ssne). AOAH aClivily is expressed as described 
in Ihe legend lo Fig. I. 
In contrast to the inereased rate of LPS deacylation pro­
duced by overexpressing AOAH in the liver, the accumulation 
of AOAH activity in plasma following infection of mice with 
Ad.CMV-AOAH was not associated with detectable in vivo 
deacylation of rough-form !,HJLPS in the plasma space; Le., 
ethanol-soluble ~H in plasma 30 min following administration 
of [3H]LPS was not increased in Ad.CMV-AOAH-infected 
mice, despite the presence of increased levels of assayable 
AOAH in plasma (data not shown). AJthough the rapid clear­
ance of rough-form LPS from the circulation allowed a rela­
tively brief time period for intravascular deacyJalion to Occur, 
accumulation of AOAH in plasma also did not significantly 
alter the rate of clearanec of smooth-form [3H)LPS from the 
plasma space (Fig. 4) or enhance its deacylation in plasma 
(data not shown). The unavailabilily of smooth LPS radiola­
beled to high specific aClivity in the acyl chains precluded a 
sensitive assessment of its deaeylation in vivo, however. An­
other potential explanation for low plasma deacylation rates 
could be the uptake of LPS-derived 'H-fatty acids from plasma 
by various tissues; the lack of correlation between plasma and 
liver ethanol-soluble 1H argues against this possibility. 
While clearance of a small or large amount of smooth·form 
LPS was not altered hy overexpression of AOAH, we did 
observe that infection of mice with recombinant adenovirus 
per se altered the uptake of rough-form [JH]LPS into the liver 
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TABLE 1. Impact of viral infection on the tissue uptake and deacylalion of intravenously injected TOugh ['HILPS Q
 
Group n 
PI,,"," 
%. Injected I'HlLPS in: 
Llvt'.r Spl.;.n 
Spleen weighl 
(mg) 
% I'HJLPS 
deaeylatlon" 
Salinc injected 5 4.6 ±. 1.4 50.1 ± 8.4 1.8 ±. 0.3 110 ±. 17 1.3 ± 0.1 
Ad.CMV-13Gal infectcd 7 13.2 ±. 4.4' 23,0:t 3.2' 143 ± 2.3' 184 :t 27" 1.5 :!: 0.1 
Ad.CMV-AOAH infected 13 13.7 :t 4.5' 24.R:t 2,7' 11.3 :!: 4.0­ 17{) ± 27' 43 ±. 0.7" 
Q Three days afler mjecl;on wilh sahne or 1.5 x 10' PFU of one oUhe mdleated adcn"vlru~es, each mouse received a 10')Lg imravenou. injection ofl'HJLPS TIssue, 
were weighed and hnmngen).7ed 10 min ]aler, and aUqunlS were (Olmled lO determine "1H cnnlenL. Data m(Jicalc means :t .t'l'mdard devlalion~_ ~agnlticantly diflerenlIt: , 
from saline-injecled group (P < 0.(5); ''', signifieanlly dliler.nl (rom lhe other groups (P < 0.(5). 
o Pereenl deac)'latlon ~ iOO x [(clhanol-soluble 'H dpm)/(lotal 'H dpm)1 JIl hver homogenales. 
and spleen and, in some experiments. modestly delaycd its 
clearance from plasma (Table 1). When compared with unin­
fecled control animals, animals infccted with cither Ad.CMV­
AOAH or Ad.CMV-~Gal showed a fractional reduction in 
hepatic uptake of rough-form [)H)LPS and an increase in 
fractional splenic uptakc. Infection of mice with first-genera­
tion recombinant adenovirus vectors is associated with an 
acutc lymphocytic hepatitis (28). Consistent with this phcnom­
enon, we observed an increase in serum alanine aminolrans­
ferase levels 6 days following infection with 2.0 X lO~ PFU of 
recombinant adenovirus in comparison with that of saline­
injected control animals (404 :!:: 447 IU/ml [11 = 8) versus 34 :!:: 
4 Wlml [Il = 4], P = 0.05). It is possihle that the delayed 
plasma clearance and altered tissue distribution of intrave­
nously injected rough-form [~H)LPS resulted from this viral 
vector-associated hepatoeellular injury. In addition, animals 
infected with either Ad,CMV-AOAH 0, Ad.CMV-~Gal dem­
onstraled noticeable splenic enlargement 3 to 4 days after 
infection, and spleen weights in both groups were significantly 
greater (by approximately 50%) than those in saline-injected 
controls (Table 1). 
In the course of these experimeuts, several groups of animals 
were infected with Ad.CMV-AOAH. We obscrved consider­
able mouse-to-mouse variability in the levels of hepatic and 
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FIG. 4. Clearance of rough and smooU, fHJLPS from plasma Groups of Ilve 
or six mice were injecled with labeled rough LPS (R-LPS) or smoolh LPS 
(S-LPS) 3 days afler injection wilh 250 )LJ oj saline (open circles) or an equal 
volume of salille containing 10' PFU of Ad.CMV-I3Gal (dosed Iriangles) or 
Ad.CMV·AOAli (open squar"s). Al intervals folluwlng injeclion ul radlulaboled 
LPS. blood ,amples were oblained Jor delermlnalion of lhe amount of the lracer 
remaining In the clrcu)alJUII. Oala are expressed as the mean 11'actlOn (pcn.:enl) 
of the tral;cr remaining In hlood at the time indicated. The dalii shown for 
smooth LPS arc tram one of three e),,'Periment.s wl1.h Similar r~$ull~. Lv., inlra· 
vennus. 
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plasma AOAH activities, dcspite careful efforts to standardize 
the procedure for administration of virus (injections in any 
group were performed within 1 h by an experienced tcchnician 
with a single virus preparation and no observed loss of inocu­
lum). To invest.igate the cause of this interanimal variation, we 
performed several additional experiments. First, we measured 
hepatic AOAH expression in groups (11 = 11 to 13 per group) 
of male ICR (outbred) and BALB/c (inbred) mice. Both 
strains demonstrated simila, variability in hepatic AOAH ac­
tivilY (ranging from 3- to 21-fold belween the highest and 
lowcst producers in individual groups). Second, we infected 
ICR mice with an inoculum containing both Ad.CMV-AOAH 
(1.5 X lOy PFU) and Ad.CMV-Luc (a recombinant adenovirus 
carrying a gene encoding firefly luciferase; 0.25 x 109 PFU) 
and determined the activities of both enzymes in hepatic tissue 
3 days after infection. We observed a strong correlation be­
tween the levels of AOAH and luciferase in hepatic tissue 
harvested from these animals (Fig. 5). Finally, repeated exper­
iments with different batches of recombinant virus demon­
strated similar ranges of interanimal variation in the levels of 
expressed AOAH aetjvity. These experiments suggest that the 
variation in the levels of AOAH activity observed in the liver 
following administration of Ad.CMV-AOAH resulted from 
variability in the efficiency of hepatic infection rather than 
from virus-, barch-, recombinant protein-, or mouse strain­
related factors. Adenoviral infection might be affected by diet, 
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FIG. 5. Correlation belween hepalie AOAH and Ineiterase aelivilles in miee 
infecled wilh both Ad.CMV-AOAH and Ad.CMV-Luc.ICR mice (/1 = 15) were 
Injected with 250 1'-1 ors"Jine conlalnlng 1.5 X !O"I'FU uf Ad.CMV·AOAH and 
0.25 x 10" PFU uf Ad.CMV-LuL Aller :I days, liver l'S'UL' waS harvc'lcd "m) 
ht::.patlc AOAli and luclferasc aclivilies were determined as: descTlbt:.d in Male­
nals and Methods. AOAlI aCllvlly IS cxprcs,ed as described In the legcnd lO F1~. 
1. Lucllerast: aClivily 1$ t:xpressed a!': light unll-S (Hl~) per mi'ligram at tistiue. Eal:h 
roml represents r~sull~ (rom a SIngle animal. 
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endotoxin absorption from the gut. subclinical infection, or 
other unmeasured variables. 
DISCUSSION 
The experiments describcd here demonstrate that human 
AOAR catalyzes the enzymatic deacylation of bacterial LPS in 
vivo and that introduction of a constitutivc gene encoding this 
enzyme into the liver in mice substantially enhances the rale at 
which rough-form LPS undergoes hepatic deacylation. With 
prior studies demonstrating that dLPS both competitively in­
hibits binding of LPS to CD14 (14) and interferes with other 
steps in the LPS signal transduction pathway to antagonize 
LPS-induced activation of human cells (14, 15), overexpression 
of AOAR might be expected to exert a protective effeet against 
an excessive endotoxin response. In this regard, the present 
observations in mice are more cautionary than enthusiastic. 
Our results suggest that the rates of tissue uptake and deacy­
lation of LPS are not tightly linked. Deacylation of intrave­
nously injected LPS normally occurs slowly in rodent livers (4), 
consistent with the low deacylation rates seen in control ani­
mals in this study (Fig. 3 and Table 1). Although AOAH has 
not heen demonstrated in hepatocytes, LPS-deal;ylating activ­
ity has been described in these cells (5). Overexpression of 
AOAR increased the rate of LPS deacylation in the liver 
severalfold, suggesting that enzymatic activity, rather than sub­
strate availability (i.e., the rate of LPS internalization), is rate 
limiting for deacylation. In fact, hepatie deacylation increased 
despite a faJl in the fractional hepatic uptake of the tracer (and 
thus an absolute reduction in [3HJLPS uptake), again suggest­
ing that, at least in hepatocyles, low enzymatic activity nor­
mally limits the rale of LPS deacylation. A similar rclationship 
may pertain to human neutrophils, which internalize LPS 
much morc rapidly than they deacylate it (19). Enhancing 
intracellular LPS deacylation in hepatocytes or neutrophils 
should thus not interfere with LPS signals that are transduced 
from the cell surface, but it Blight diminish the ability of LPS 
to signal at intracellular sites or to stimulate other eells if 
exocytosed. Hepatic LPS degradation in vivo normally occurs 
very slowly over time (16), and the longer-term consequences 
of accelerating this process have not heen explored. 
When challenged intravenously with LPS, rabbits rapidly 
accumulate AOAR activity in plasma (2). IfAOAR deacylates 
LPS in plasma, the enzyme might be a host mechanism for 
avoiding the deleterious effects of endotoxemia. Although 
AOAH has substantial (approximately one-third of maximal) 
activity at pH 7.4 when assayed in a detergent-containing 
buffer system in vitro (11), it has not been possible to demon­
strate deacylation of LPS in near plasma or serum (2). In the 
presenl experiments, we found that adenovirus-mediated 
transfer of the AOAH gene generated high levels of recombi­
nant AOAH in plasma. This accumulation of plasma AOAH, 
detected by its aetivity in the in vitro assay system. was not 
associated with demoustrable dcacylation of LPS in plasma, 
howevcr, suggesting that AOAH is not catalytically active to­
ward LPS in vivo in the plasma space. Similarly, the lack of a 
discernible effect on LPS clearance suggests that AOAR may 
not bind LPS in plasma. Highly purified LPS may not be the 
appropriate substrate for AOAH in vivo, however, wherc LPS 
is released from bacteria in membrane fragments that include 
prolein and phospholipid and where numerous other potential 
substrates for AOAH (which is also a phospholipase A [24]) 
are present. 
Although the adenoviral vector used for these experiments 
provided a convenient and effective mechanism for overpro­
ducing AOAR in mice, it also imposcd several important lim-
INFEcr. JMMUN. 
itations. First, since the virus predominantly infects hepato­
cytes, it did nOl augment AOAH activity selectively in lhe 
phagocylic cells (neutrophils and monocytes/macrophages) 
that normally express the enzyme. (For example, fractional 
LPS deacylation was not enhanced in the spleens of mice that 
received Ad.CMV-AOAR [data not shown], despite greatly 
increased splenieAOAR activity [Fig. 1).) Although we did not 
identify the adenovirus-infected cells in the spleen, they may 
not be the phagocytic cells that take up LPS). It is possible that 
overexpression of AOAH in phagocytic cclls could influence 
phenomena such as the persistenee of the in vivo response to 
LPS, LPS adjuvanlicity, endotoxin tolerancc, and chronic LPS­
induced inflammation. Second, adenoviral infection induces an 
inflammatory response that, as shown here, produces hepatitis 
and splenomegaly, alters lhe tissuc distribution of intrave­
nously injected LPS, and induces low-level increases in AOAR 
act.ivity. Third, substantial heterogeneity in adenovirus-medi­
ated recombinant protein expression was found even in inbred 
mice. Such variability, while anticipated in any biological sys­
tem, greatly increases the numbers of animals needed to study 
the impact of recombinant protein expression on a phenome­
non, sueh as LPS-induced inflammalion, (hal is itself highly 
variable in its severity. 
While the activity of AGAR and [he effects of dLPS have 
been charaelerized in cultured cclls. potential function(s) of 
LPS deacylation in vivo have not been examined previously. 
These studies showcd that mice infected with a recombinanl 
adenovirus carrying a constitutive AOAR gene can transiently 
express high levels of AGAR activity in several tissues without 
ovcrt toxicity from the recombinant protein. Ovcrexpression of 
AGAR in the liver was associated with a substantial increase in 
the rate of hepalic dcacylation of mdiolabeled rough-form LPS 
in vivo without a discernible impact on LPS plasma clearance. 
In addition, plasma levels of AOAR activity were significantly 
increased, yet increased LPS deacylation in plasma was not 
detected. Although intcrpretation of these data is complicated 
by several technical limitations, as noted above, the studies 
represent an initial step toward determining the roles of 
AOAR and LPS deacyJation in animals. Efforts to augment 
AOAH expressiou in phagocytic cells and to eliminate AOAR 
expression by targeted disruption of the murine AGAR gene 
should providc more definitive insights regarding thc role of 
this enzyme, and its products, in vivo. 
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